000			01946 a2200505 4500
005			20250516050039.0
264		0	_c20120627
008			201206s 0 0 eng d
022			_a1872-8332
024	7		_a10.1016/j.lungcan.2011.06.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aAerts, Hugo J W L
245	0	0	_aIdentification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. _h[electronic resource]
260			_bLung cancer (Amsterdam, Netherlands) _cJan 2012
300			_a73-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdiagnostic imaging
650	0	4	_aChemoradiotherapy _xmethods
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aFluorodeoxyglucose F18 _xpharmacokinetics
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdiagnostic imaging
650	0	4	_aMiddle Aged
650	0	4	_aPositron-Emission Tomography _xmethods
650	0	4	_aProspective Studies
650	0	4	_aRadiopharmaceuticals _xpharmacokinetics
650	0	4	_aRadiotherapy Planning, Computer-Assisted
650	0	4	_aTomography, X-Ray Computed _xmethods
650	0	4	_aTumor Burden _xradiation effects
650	0	4	_aGemcitabine
700	1		_aBussink, Johan
700	1		_aOyen, Wim J G
700	1		_avan Elmpt, Wouter
700	1		_aFolgering, Annemieke M
700	1		_aEmans, Daisy
700	1		_aVelders, Marije
700	1		_aLambin, Philippe
700	1		_aDe Ruysscher, Dirk
773	0		_tLung cancer (Amsterdam, Netherlands) _gvol. 75 _gno. 1 _gp. 73-6
856	4	0	_uhttps://doi.org/10.1016/j.lungcan.2011.06.003 _zAvailable from publisher's website
999			_c21029073 _d21029073